Patents by Inventor Randal Keith Gregg

Randal Keith Gregg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for endocytic presentation of an immunosuppressive for the treatment of type 1 diabetes
    Patent number: 8609091
    Abstract: The present invention relates generally to methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes. More specifically, the present invention relates to the administration of a fusion protein comprising at least one immunoglobulin having one or more diabetogenic epitopes inserted within the variable region, for suspending, preventing or delaying the onset of type 1 diabetes.
    Type: Grant
    Filed: October 8, 2003
    Date of Patent: December 17, 2013
    Assignee: The Curators of the University of Missouri
    Inventors: Habib Zaghouani, Randal Keith Gregg
  • Methods and compositions for preventing the onset of type 1 diabetes
    Patent number: 8603471
    Abstract: The present invention relates generally to methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes. More specifically, the present invention relates to the administration of a fusion protein comprising at least one immunoglobulin having one or more diabetogenic epitopes inserted within the variable region, for suspending, preventing or delaying the onset of type 1 diabetes in a pre-diabetic subject.
    Type: Grant
    Filed: November 29, 2005
    Date of Patent: December 10, 2013
    Assignee: The Curators of the University of Missouri
    Inventors: Habib Zaghouani, Randal Keith Gregg
  • TREATMENT OF TYPE 1 DIABETES BEFORE AND AFTER EXPRESSION OF PREDISPOSITION MARKERS
    Publication number: 20100278823
    Abstract: The present invention relates generally to the use of compounds, compositions, combinations, kits, and methods for the effective endocytic presentation of immunosuppressive factors for the down regulation of diabetogenic T cells for the treatment of type 1 diabetes.
    Type: Application
    Filed: May 4, 2010
    Publication date: November 4, 2010
    Applicant: THE CURATORS OF THE UNIVERSITY OF MISSOURI
    Inventors: Habib Zaghouani, Randal Keith Gregg
  • Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes
    Patent number: 7744876
    Abstract: The present invention relates generally to methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes. More specifically, the present invention relates to the administration of a fusion protein comprising at least one immunoglobulin having one or more diabetogenic epitopes inserted within the variable region, for suspending, preventing or delaying the onset of type 1 diabetes.
    Type: Grant
    Filed: April 8, 2003
    Date of Patent: June 29, 2010
    Assignee: The Curators of the University of Missouri
    Inventors: Habib Zaghouani, Randal Keith Gregg
  • Sustained treatment of type 1 diabetes after expression of predisposition markers
    Publication number: 20040126374
    Abstract: The present invention relates generally to the use of compounds, compositions, combinations, kits, and methods for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes.
    Type: Application
    Filed: October 8, 2003
    Publication date: July 1, 2004
    Applicant: THE CURATORS OF THE UNIVERSITY OF MISSOURI
    Inventors: Habib Zaghouani, Randal Keith Gregg